
Calcium Folinate/Pharmazac has just been launched
October 17, 2018
Pharmazac launches Apregalin® (pregabalin)
April 10, 2019Vasitimb®, the new ezetimibe + simvastatin combination, has just been launched

Pharmazac has just launched the new product Vasitimb (ezetimibe + simvastatin) for the prevention of cardiovascular events, for hypercholesterlaemia and the Homozygous Familial Hypercholesterolaemia.
Vasitimb
is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments (e.g., low-density lipoprotein [LDL] apheresis).
Related News
November 4, 2026
Pharmazac at MPRAD 2026: Advancing Cardiac Imaging
The “3rd Panhellenic Conference of Medical Physics & 27th Inter-University Conference of Radiology”, held on 30–31 October and 1 November at the University of Thessaly in […]
October 12, 2026
Pharmazac, strong in Contract Development and Manufacturing Services
Pharmazac was delighted to be featured in the “Health” supplement of the prestigious newspaper “TO VIMA” on Sunday, October 11. Through an advertorial highlighting its participation […]
October 8, 2026
Pharmazac maintained a strong presence at CPhI 2026
Marking forty years in the pharmaceutical market this year, Pharmazac chose to celebrate the milestone with an even more dynamic presence at the international Convention on […]
September 26, 2026
Anniversary feature in KATHIMERINI’s “Golden Anniversaries”
We are honoured to be featured in “Golden Anniversaries 2026”, a special supplement by ICAP CRIF published with KATHIMERINI on 26 September 2026. The edition celebrates […]
